Guidant's DISCOVERY II pacemaker gets US approval:
This article was originally published in Clinica
Executive Summary
Guidant has received US FDA approval for its DISCOVERY II single sensor pacemaker. The device will complement another of the company's sensor products, the PULSAR MAX pacemaker. The DISCOVERY II is designed to simplify clinician interaction with a pacemaker, enabling physicians to easily and efficiently perform comprehensive tests and follow-up operations. The device also provides a concise report that presents information needed for patient management.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.